Camps et al. (2013) found that siRNA down-regulation of CAT -1 expression can reduce the survival rate of cancer cells, and significantly inhibit the expression of growth factor Epiregulin (EREG), which is a key factor in the transformation of colon from inflammation to tumor. The gene discussed is GIT1; the disease is neoplasm.